Related Experiment Video
Updated: May 27, 2026
06:22
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Diabetes and cardiovascular disease.
1Cardiovascular Services, Baylor University Medical Center, 3500 Gaston Avenue, Dallas, TX 75246, USA. Bobbi.Leeper@baylorhealth.edu
Critical Care Nursing Clinics of North America
|November 29, 2011
Summary
Effective inpatient glucose control requires careful management to prevent blood glucose (BG) swings and hypoglycemia. Multidisciplinary teams and ongoing staff education are crucial for developing and implementing safe insulin protocols.
Area of Science:
- Clinical Medicine
- Endocrinology
- Nursing
Background:
- Inpatient glucose control presents significant clinical challenges.
- Avoiding blood glucose (BG) variability and hypoglycemia is critical for patient safety.
Purpose of the Study:
- To highlight the complexities of inpatient glycemic management.
- To emphasize the need for standardized protocols and comprehensive staff education.
Main Methods:
- Involves nurses in developing insulin protocols and physician order sets for clarity.
- Recommends regular, interval-based education for nursing and physician staff.
- Suggests establishing multidisciplinary teams for quality improvement projects.
Main Results:
- Multidisciplinary teams can develop quality improvement projects for monitoring and process improvement.
- Continuous monitoring of practices helps reduce errors and supports safe patient care.
- No official guidelines currently exist for inpatient glycemic control quality.
Conclusions:
- Collaboration among physicians, nurses, and pharmacists is essential.
- Standardized protocols, clear communication, and ongoing education are key to improving inpatient glycemic control.
- Proactive monitoring and process improvement initiatives are vital for safe practices.
Related Concept Videos
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:22Complications of Diabetes Mellitus
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...